Scarica l'app Stockscreener
18.89
0.32%
0.06
Dopo l'orario di chiusura:
18.78
-0.11
-0.58%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVDL Giù?
Forum
Previsione
Precedente Chiudi:
$18.83
Aprire:
$18.8
Volume 24 ore:
3.18M
Relative Volume:
1.32
Capitalizzazione di mercato:
$1.83B
Reddito:
$221.08M
Utile/perdita netta:
$-2.92M
Rapporto P/E:
-572.42
EPS:
-0.033
Flusso di cassa netto:
$5.89M
1 W Prestazione:
+1.78%
1M Prestazione:
+23.71%
6M Prestazione:
+112.49%
1 anno Prestazione:
+22.11%
Intervallo 1D:
$18.73
$19.06
Intervallo di 1 settimana:
$18.54
$19.06
Portata 52W:
$6.38
$19.06
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Nome
Avadel Pharmaceuticals Plc
Settore
Telefono
636-449-1830
Indirizzo
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Confronta AVDL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
18.89 | 1.83B | 221.08M | -2.92M | 5.89M | -0.033 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-09-03 | Iniziato | Wells Fargo | Equal Weight |
| 2025-07-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-06-12 | Iniziato | Rodman & Renshaw | Buy |
| 2024-03-05 | Reiterato | H.C. Wainwright | Buy |
| 2024-03-05 | Reiterato | Needham | Buy |
| 2024-03-05 | Reiterato | Oppenheimer | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2022-11-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-08-10 | Downgrade | Jefferies | Buy → Hold |
| 2022-07-28 | Ripresa | Craig Hallum | Buy |
| 2022-05-26 | Downgrade | Stifel | Buy → Hold |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2020-07-31 | Iniziato | Oppenheimer | Outperform |
| 2020-07-21 | Iniziato | SVB Leerink | Outperform |
| 2020-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-03 | Iniziato | Jefferies | Buy |
| 2020-03-12 | Iniziato | Stifel | Buy |
| 2020-02-26 | Iniziato | Piper Sandler | Overweight |
| 2020-01-30 | Iniziato | Craig Hallum | Buy |
| 2019-06-14 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
Mostra tutto
Avadel Pharmaceuticals Plc Borsa (AVDL) Ultime notizie
Citadel Group discloses 1.98% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Bank of America discloses 3% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Bank of America discloses 3% stake in Avadel Pharmaceuticals - Investing.com
Is Avadel Pharmaceuticals plc stock supported by strong fundamentals2025 Earnings Impact & Fast Moving Stock Watchlists - newser.com
Can Avadel Pharmaceuticals plc stock deliver sustainable ROEJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
Can Avadel Pharmaceuticals plc stock maintain growth trajectoryJuly 2025 Patterns & Stock Market Timing Techniques - newser.com
Real time breakdown of Avadel Pharmaceuticals plc stock performanceJuly 2025 Decliners & Verified Swing Trading Watchlists - newser.com
Will a bounce in Avadel Pharmaceuticals plc offer an exitEntry Point & Long-Term Safe Return Strategies - newser.com
Morgan Stanley discloses dealing in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Morgan Stanley discloses dealing in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com
What insider trading reveals about Avadel Pharmaceuticals plc stockAnalyst Downgrade & Consistent Return Strategy Ideas - newser.com
Leading vs lagging indicators on Avadel Pharmaceuticals plc performanceTrend Reversal & Low Risk Entry Point Guides - newser.com
How risky is Avadel Pharmaceuticals plc stock nowEarnings Beat & Safe Swing Trade Setups - newser.com
Can Avadel Pharmaceuticals plc stock rebound after recent weaknessStock Surge & Scalable Portfolio Growth Ideas - newser.com
Why Avadel Pharmaceuticals plc stock is a value investor pick2025 Momentum Check & Low Drawdown Trading Strategies - newser.com
How Avadel Pharmaceuticals plc (AWK) stock performs in volatility spikes2025 Momentum Check & High Accuracy Investment Signals - newser.com
How strong is Avadel Pharmaceuticals plc (AWK) stock earnings growthPortfolio Risk Report & Risk Adjusted Buy/Sell Alerts - newser.com
Published on: 2025-10-31 00:36:25 - newser.com
How interest rate cuts could boost Avadel Pharmaceuticals plc stockWeekly Investment Recap & Weekly Return Optimization Plans - newser.com
How Avadel Pharmaceuticals plc (AWK) stock reacts to stronger dollar2025 Performance Recap & Advanced Swing Trade Entry Plans - newser.com
Avadel Pharmaceuticals (NASDAQ:AVDL) Hits New 1-Year HighWhat's Next? - MarketBeat
Bank of America discloses 2.98% stake in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading activity in Avadel Pharmaceuticals - Investing.com
Strategies to average down on Avadel Pharmaceuticals plcMarket Growth Review & Capital Protection Trade Alerts - newser.com
Will earnings trigger a reversal in Avadel Pharmaceuticals plc2025 Market Sentiment & Reliable Price Action Trade Plans - newser.com
Is Avadel Pharmaceuticals plc stock positioned well for digital economyMarket Trend Review & High Conviction Buy Zone Picks - newser.com
Statistical indicators supporting Avadel Pharmaceuticals plc’s strengthPortfolio Value Summary & Low Risk High Reward Trade Ideas - newser.com
Is Avadel Pharmaceuticals plc (AWK) stock cheap vs fundamentalsWeekly Trade Recap & Community Verified Trade Signals - newser.com
Is Avadel Pharmaceuticals plc stock a buy before product launchesMarket Trend Report & Smart Swing Trading Alerts - newser.com
Is Avadel Pharmaceuticals plc stock bottoming outFed Meeting & Smart Money Movement Tracker - newser.com
Published on: 2025-10-30 01:05:36 - newser.com
BlackRock discloses 6.81% stake in Avadel Pharmaceuticals - Investing.com India
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares - Investing.com
BlackRock discloses 6.81% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com India
Tudor Investment Corporation discloses stake in Avadel Pharmaceuticals By Investing.com - Investing.com Philippines
Avadel Pharmaceuticals Plc Azioni (AVDL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Avadel Pharmaceuticals Plc Azioni (AVDL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Thornton Peter J. | Director |
Jan 13 '25 |
Buy |
8.04 |
10,000 |
80,450 |
104,055 |
| Ende Eric J | Director |
Jan 13 '25 |
Buy |
7.84 |
30,000 |
235,218 |
208,900 |
| MCHUGH THOMAS S | Chief Financial Officer |
Dec 13 '24 |
Buy |
10.44 |
2,300 |
24,019 |
87,800 |
| MCHUGH THOMAS S | Chief Financial Officer |
Dec 11 '24 |
Buy |
10.49 |
5,000 |
52,432 |
85,500 |
| Divis Gregory J | Chief Executive Officer |
Dec 06 '24 |
Buy |
9.98 |
9,598 |
95,759 |
9,598 |
| Divis Gregory J | Chief Executive Officer |
Dec 09 '24 |
Buy |
9.82 |
402 |
3,948 |
10,000 |
| Glass Geoffrey Michael | Director |
Dec 10 '24 |
Buy |
9.84 |
20,279 |
199,641 |
75,904 |
| Palczuk Linda | Director |
Dec 06 '24 |
Buy |
10.19 |
3,000 |
30,568 |
66,400 |
3.18%
1.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):